tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Dogwood Therapeutics Reports Progress in Pain Treatment Trials
PremiumCompany AnnouncementsDogwood Therapeutics Reports Progress in Pain Treatment Trials
3M ago
Dogwood reports Q1 EPS ($8.45) vs. ($1.68) last year
Premium
The Fly
Dogwood reports Q1 EPS ($8.45) vs. ($1.68) last year
3M ago
Dogwood sees cash runway through 1Q26
Premium
The Fly
Dogwood sees cash runway through 1Q26
3M ago
Dogwood management to meet with Maxim
PremiumThe FlyDogwood management to meet with Maxim
4M ago
Dogwood regains Nasdaq compliance
Premium
The Fly
Dogwood regains Nasdaq compliance
4M ago
Dogwood Therapeutics Reports 2024 Financial Results and Strategic Progress
Premium
Company Announcements
Dogwood Therapeutics Reports 2024 Financial Results and Strategic Progress
4M ago
Dogwood prices 578,950 shares at $8.26 in registered direct offering
PremiumThe FlyDogwood prices 578,950 shares at $8.26 in registered direct offering
4M ago
Dogwood Therapeutics Strengthens Balance Sheet with Debt Conversion
Premium
Company Announcements
Dogwood Therapeutics Strengthens Balance Sheet with Debt Conversion
4M ago
Dogwood announces conversion of existing $19.5M in debt to equity
Premium
The Fly
Dogwood announces conversion of existing $19.5M in debt to equity
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100